Table 6. Multivariate linear regression analysis on factors related to the total out-of-pocket costs stratified by study setting*.
Variables | Coefficient | 95% CI | t | P |
---|---|---|---|---|
ZJG | ||||
Age group | ||||
<60 | Ref. | |||
≥60 | -0.607 | -0.978, -0.235 | -3.22 | 0.001 |
Residence | ||||
Local patient | Ref. | |||
Migrant patient | 0.486 | 0.160, 0.812 | 2.93 | 0.004 |
Diagnosis delay | ||||
<2 weeks | Ref. | |||
≥2 weeks | 0.326 | 0.038, 0.614 | 2.23 | 0.026 |
Hospitalization | ||||
No | Ref. | |||
Yes | 1.724 | 1.411, 2.038 | 10.83 | <0.001 |
TX | ||||
Age group | ||||
<60 | Ref. | |||
≥60 | -0.345 | -0.561, -0.129 | -3.15 | 0.002 |
Clinical visits | ||||
<7 times | Ref. | |||
≥7 times | 0.579 | 0.353, 0.805 | 5.05 | <0.001 |
Diagnosis delay | ||||
<2 weeks | Ref. | |||
≥2 weeks | 0.419 | 0.161, 0.677 | 3.20 | 0.002 |
Hospitalization | ||||
No | Ref. | |||
Yes | 1.664 | 1.365, 1.962 | 10.97 | <0.001 |
Intake of second-line drugs | ||||
No | Ref. | |||
Yes | 0.397 | 0.178, 0.616 | 3.57 | <0.001 |
Intake of liver protective drugs | ||||
No | Ref. | |||
Yes | 0.386 | 0.112, 0.659 | 2.77 | 0.006 |
*Total out-of-pocket costs was logarithmically transformed.